Medical Tubing Market - Global Forecast To 2030
商品番号 : SMB-8739
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年3月 |
| ページ数 | 253 |
| 図表数 | 291 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
医療用チューブ市場 – 材質（プラスチック、ゴム、特殊ポリマー）、用途（バルク使い捨てチューブ、カテーテルおよびカニューレ、薬物送達システム）、構造（シングルルーメン、マルチルーメン、共押し出し、テーパーまたはバンプ、編組） – 2030年までの世界予測
Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), Structure (Single-Lumen, Multi-Lumen, Co-Extruded, Tapered or Bump, Braided) – Global Forecast to 2030
Report Overview
The medical tubing market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period.
医療用チューブ市場は、予測期間中に年平均成長率8.0%で成長し、2025年の125億3,000万米ドルから2030年には184億1,000万米ドルに達すると予測されています。
The expansion in the medical tubing market is due to rise in cases of chronic disease, including cardiovascular conditions, cancer, and respiratory conditions. Many of these illnesses demand medical equipment like catheters, infusion equipment, and ventilators that involve tubing for treatment and management effectiveness. For example, increasing prevalence of respiratory conditions such as asthma and tuberculosis has promoted demand for ventilator tubing systems. The rise in the elderly population, also more prone to chronic diseases and surgery, is another major reason. This increase in the old age population led to an uptrend in need for minimally invasive procedures with medical tubing featuring a key element in drug administration and fluid delivery systems.
医療用チューブ市場の拡大は、心血管疾患、癌、呼吸器疾患などの慢性疾患の増加によるものです。これらの疾患の多くは、治療と管理の効率化のためにチューブを必要とするカテーテル、輸液装置、人工呼吸器などの医療機器を必要としています。例えば、喘息や結核などの呼吸器疾患の罹患率の増加は、人工呼吸器チューブシステムの需要を促進しています。高齢者人口の増加は、慢性疾患や手術のリスクを高めており、これも大きな要因です。高齢者人口の増加は、低侵襲手術のニーズ増加につながり、医療用チューブは薬剤投与システムや輸液システムの重要な要素となっています。
Moreover, companies’ strategic moves, including product launches and mergers, are broadening market coverage and visibility. Finally, rigorous regulatory requirements and government spending on healthcare infrastructure are driving market growth by providing high-quality tubing products for various applications. All these factors together put the medical tubing market in line for long-term growth in the next few years.
さらに、新製品の発売や合併といった企業の戦略的動きにより、市場カバレッジと認知度が拡大しています。さらに、厳格な規制要件と医療インフラへの政府支出は、様々な用途に高品質なチューブ製品を提供することで市場の成長を牽引しています。これらの要因が相まって、医療用チューブ市場は今後数年間、長期的な成長が見込まれます。
“Rubber is the second fastest-growing material in the medical tubing market during the forecast period.”
Rubber is the second fastest-growing medical tubing material because of its better flexibility, durability, and biocompatibility, which make it suitable for numerous medical applications. Natural and synthetic rubbers, including silicone, latex, and thermoplastic elastomers (TPE), provide good resistance to harsh temperatures, chemicals, and multiple sterilization cycles. This makes rubber tubing ideally suited to be used in catheters, respiratory therapy units, peristaltic pumps, and surgery drainage systems. Silicone rubber is specifically used on a large scale owing to its superior biocompatibility, for which it is considered a material of choice for implantable and long-term medical uses. In addition, rubber products have higher resilience that allows medical tubing to withstand bending and stretching without loss of integrity, hence offering enhanced patient comfort and device performance. The growing prevalence of chronic conditions, such as cardiovascular and respiratory diseases, has fueled the demand for medical devices that incorporate rubber tubing. In addition, advances in rubber formulations, including antimicrobial coatings and increased tensile strength, have contributed to its applications in critical care. With advances in healthcare innovation, rubber tubing continues to be a top contender, thus qualifying it as the second fastest-growing material in the medical tubing market.
“Braided tubing is the second fastest-growing structure in the medical tubing market during the forecast period.”
Braided tubing is the second fastest-growing medical tubing structure because of its excellent combination of strength, flexibility, and versatility that can address a broad spectrum of sophisticated medical uses. Its structure, with a reinforcing braided layer commonly composed of materials such as stainless steel or nylon inserted inside polymer tubing, provides the best resistance to high pressure and kinking than its non-reinforced counterparts. This makes it most appropriate for high-performance applications such as catheters, endoscopes, and cardiovascular devices, where durability and precise fluid delivery are of the highest priority. The growing need for minimally invasive procedures, which require tubing that can navigate through intricate anatomical pathways without compromising performance, significantly enhances its application. Braided tubing can withstand sterilization processes and maintain structural integrity under stress conditions also helps in meeting the strict safety requirements of the medical sector. Rising prevalence of chronic diseases, coupled with the aging population and their requirement for advanced diagnostic and therapeutic equipment, also fuels its market growth. New braiding technology and material science enable it to be even more flexible and enable customization to fulfill particular medical needs. While single-lumen tubing may be the culprit by way of simplicity and ubiquity, the greater mechanical properties and biocompatibility of braided tubing with high-performance uses position it as a fast-rising market that responds well to shifting needs of modern healthcare.
“Catheters & cannulas is the second fastest-growing structure in the medical tubing market during the forecast period.”
The catheters & cannulas market is the second fastest-growing application of the medical tubing market owing to a number of major driving factors behind its demand. As the global healthcare systems focus on minimally invasive interventions, catheters & cannulas are becoming the tools of choice, providing safer and less traumatic alternatives to conventional surgeries. These soft tubes play a vital role in uses such as cardiovascular interventions, urinary drainage, and intravenous therapy, where accuracy and patient comfort are of utmost importance. Growing prevalence of chronic illness, including cardiovascular conditions, diabetes, and renal disorders, mainly in aging communities, also catalyzes such expansion. Demand for catheterization in treatment of heart problems or urinary incontinence automatically increases demand for special tubing. Advancements in technology also are contributing factors with improved biocompatible materials, including silicone and polyurethane, improving functionality, longevity, and safety for catheters & cannulas. Besides, the move towards outpatient treatment and home healthcare increases their application in portable equipment, like infusion pumps. The segment is helped by the increasing investments in healthcare, particularly in sectors that are emerging, as enhanced infrastructure and availability of medical services increase the demand for disposable and sterile tubing.
“The Middle East and Africa (MEA) market is projected to register the second fastest growing market for medical tubing during the forecast period.”
Middle East & Africa (MEA) is the second fastest-growing market for medical tubing owing to mounting healthcare investment, enhancing medical infrastructure, and rising demand for high-tech medical devices. Regional governments, specifically those of Saudi Arabia, UAE, and South Africa, are greatly investing in the modernization of healthcare, generating the demand for superior medical tubing for usage in hospitals, clinics, and diagnostic centers. The growth of healthcare facilities, coupled with the creation of medical free zones and manufacturing centers, is increasing local production and distribution of medical tubing and associated devices. The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases has boosted the use of medical tubing in drug delivery systems, catheters, and respiratory devices. The increased geriatric population in the region also demands advanced medical treatment, thereby propelling the use of medical tubing-based applications. The transition towards home healthcare and wearable medical devices, including insulin pumps and oxygen therapy devices, is another key driver for market growth. Worldwide medical device companies are expanding their reach in the MEA region through collaborations, joint ventures, and establishing regional production units. All this growth increases the number of better-quality medical tubing products available and reduces dependency on imports, and consequently healthcare becomes affordable. Medical tubing technologies such as biodegradable and antimicrobial medical tubing grow more popular in MEA as healthcare professionals continue to prioritize infection control and eco-friendliness.
Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments and the information gathered through secondary research.
The break-up of primary interviews is given below:
- By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
- By Designation: C Level: 35%, Director Level: 30%, and Executives: 35%
- By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5%
Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are some of the key players in the medical tubing market.
The study includes an in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The market study covers the medical tubing market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on material, application, structure, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical tubing market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical tubing market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Increase in geriatric population, Increasing demand for minimally invasive medical procedures, Stringent quality standards and regulations, Advancements in extrusion technology), restraints (Limited material compatibility), opportunities (Customization and innovation in polymers and tubing structure, Increasing government expenditure for upgrading and developing healthcare infrastructure), challenges (High cost of producing and marketing medical tubing products).
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical tubing market
- Market Development: Comprehensive information about lucrative markets – the report analyses the medical tubing market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are the top manufacturers covered in the medical tubing market.
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.3.5 UNITS CONSIDERED 27
1.4 STAKEHOLDERS 27
1.5 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 30
2.1.1.1 List of key secondary sources 30
2.1.1.2 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Key data from primary sources 31
2.1.2.2 List of primary interview participants—demand and supply side 31
2.1.2.3 Key industry insights 32
2.1.2.4 Breakdown of interviews with experts 32
2.2 MARKET SIZE ESTIMATION 32
2.2.1 BOTTOM-UP APPROACH 33
2.2.2 TOP-DOWN APPROACH 33
2.3 FORECAST NUMBER CALCULATION 34
2.4 DATA TRIANGULATION 34
2.5 FACTOR ANALYSIS 35
2.6 ASSUMPTIONS 36
2.7 LIMITATIONS AND RISKS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 40
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET 40
4.2 MEDICAL TUBING MARKET, BY MATERIAL 40
4.3 MEDICAL TUBING MARKET, BY APPLICATION 41
4.4 MEDICAL TUBING MARKET, BY REGION 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Growing geriatric population 43
5.2.1.2 Increasing demand for minimally invasive medical procedures 44
5.2.1.3 Advancements in extrusion technology 45
5.2.1.4 Stringent quality standards and regulations 45
5.2.2 RESTRAINTS 46
5.2.2.1 Limited material compatibility 46
5.2.2.2 Environmental and disposal concerns 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Advancements in biocompatible and smart materials 47
5.2.3.2 Increasing government expenditure to upgrade and develop healthcare infrastructure 48
5.2.4 CHALLENGES 50
5.2.4.1 High production costs and marketing complexities 50
5.3 PORTER’S FIVE FORCES ANALYSIS 51
5.3.1 THREAT OF NEW ENTRANTS 52
5.3.2 THREAT OF SUBSTITUTES 52
5.3.3 BARGAINING POWER OF SUPPLIERS 52
5.3.4 BARGAINING POWER OF BUYERS 52
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 53
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 53
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 53
5.4.2 BUYING CRITERIA 54
5.5 MACROECONOMIC INDICATORS 54
5.5.1 GLOBAL GDP TRENDS 54
6 INDUSTRY TRENDS 58
6.1 INTRODUCTION 58
6.2 VALUE CHAIN ANALYSIS 58
6.3 REGULATORY LANDSCAPE 59
6.3.1 REGULATIONS 59
6.3.1.1 North America 60
6.3.1.2 Asia Pacific 60
6.3.1.3 Europe 60
6.3.2 STANDARDS 61
6.3.2.1 ISO standard 61
6.3.2.2 Food and drug administration (FDA) 61
6.3.2.3 ASTM (American society for testing and materials) standards 61
6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
6.4 TRADE ANALYSIS 64
6.4.1 IMPORT SCENARIO (HS CODE 3917) 64
6.4.2 EXPORT SCENARIO (HS CODE 3917) 65
6.5 ECOSYSTEM ANALYSIS 66
6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 67
6.7 CASE STUDY ANALYSIS 68
6.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS 68
6.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING 69
6.8 TECHNOLOGY ANALYSIS 69
6.8.1 KEY TECHNOLOGIES 69
6.8.1.1 Extrusion technology 69
6.8.1.2 Advanced material technologies 70
6.8.2 COMPLEMENTARY TECHNOLOGIES 70
6.8.2.1 Smart technologies and connectivity 70
6.8.2.2 Surface treatment and modification 71
6.9 KEY CONFERENCES AND EVENTS, 2025 71
6.10 PATENT ANALYSIS 72
6.10.1 METHODOLOGY 72
6.10.2 DOCUMENT TYPES 72
6.10.3 PUBLICATION TRENDS IN LAST 11 YEARS 73
6.10.4 INSIGHTS 73
6.10.5 LEGAL STATUS OF PATENTS 73
6.10.6 JURISDICTION ANALYSIS 74
6.10.7 TOP APPLICANTS 75
6.11 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET 76
6.12 PRICING ANALYSIS 76
6.12.1 AVERAGE SELLING PRICE, BY REGION, 2021–2024 76
6.12.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024 77
6.12.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021–2024 77
6.13 INVESTMENT AND FUNDING SCENARIO 78
7 MEDICAL TUBING MARKET, BY APPLICATION 79
7.1 INTRODUCTION 80
7.2 BULK DISPOSABLE TUBING 81
7.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET 81
7.2.2 DIALYSIS TUBING 82
7.2.2.1 Growing aging population to drive demand 82
7.2.3 INTRAVENOUS TUBING 82
7.2.3.1 Technological advancements to drive market 82
7.3 CATHETERS & CANNULAS 82
7.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO FUEL MARKET GROWTH 82
7.3.2 CATHETERS 83
7.3.2.1 Increase in chronic diseases contributing to significant demand 83
7.3.2.2 Cardiovascular catheters 83
7.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to propel market 83
7.3.2.3 IV catheters 83
7.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth 83
7.3.2.4 Urinary catheters 84
7.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand 84
7.3.3 CANNULAS 84
7.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth 84
7.4 DRUG DELIVERY SYSTEMS 85
7.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND 85
7.4.2 NASOGASTRIC 85
7.4.2.1 Need for enteral feeding and drainage to fuel demand 85
7.4.3 NEBULIZERS 85
7.4.3.1 Conversion of liquid medications to mists for inhalation to drive market 85
7.5 OTHER APPLICATIONS 86
7.5.1 PERISTALTIC PUMP TUBING 86
7.5.1.1 Wide demand for minimizing contamination to boost market 86
7.5.2 GAS SUPPLY TUBING 86
7.5.2.1 Increasing minimally invasive surgeries to support market growth 86
7.5.3 SMOKE EVACUATION TUBING 86
7.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market 86
8 MEDICAL TUBING MARKET, BY MATERIAL 87
8.1 INTRODUCTION 88
8.2 PLASTICS 89
8.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET 89
8.2.2 POLYVINYL CHLORIDE (PVC) 89
8.2.3 POLYOLEFIN 90
8.2.3.1 Polyethylene (PE) 90
8.2.3.2 Polypropylene (PP) 90
8.2.4 POLYAMIDE 91
8.2.5 POLYTETRAFLUOROETHYLENE (PTFE) 91
8.2.6 POLYETHER ETHER KETONE (PEEK) 91
8.2.7 POLYCARBONATE (PC) 92
8.3 RUBBERS 92
8.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND 92
8.3.2 THERMOPLASTIC ELASTOMER (TPE) 92
8.3.3 THERMOPLASTIC POLYURETHANE (TPU) 92
8.3.4 SILICONE 93
8.3.5 POLYURETHANE (PU) 93
8.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM) 93
8.3.7 LATEX 93
8.4 SPECIALTY POLYMERS 94
8.4.1 DEMAND FOR SPECIALIZED TREATMENT TO BOOST MARKET 94
8.4.2 BIOABSORBABLE POLYMERS 94
8.4.3 ETHYLENE VINYL ACETATE (EVA) 94
8.5 OTHER MATERIALS 94
9 MEDICAL TUBING MARKET, BY STRUCTURE 95
9.1 INTRODUCTION 96
9.2 SINGLE-LUMEN 98
9.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET 98
9.3 CO-EXTRUDED 98
9.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET 98
9.4 MULTI-LUMEN 99
9.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND 99
9.5 TAPERED OR BUMP TUBING 99
9.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET 99
9.6 BRAIDED TUBING 100
9.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO PROPEL MARKET 100
10 MEDICAL TUBING MARKET, BY REGION 101
10.1 INTRODUCTION 102
10.2 NORTH AMERICA 103
10.2.1 US 107
10.2.1.1 High disposable income and strong healthcare infrastructure to drive market 107
10.2.2 CANADA 108
10.2.2.1 Aging population and increasing healthcare expenditure to support market growth 108
10.2.3 MEXICO 110
10.2.3.1 High investments and low manufacturing costs to fuel demand 110
10.3 EUROPE 112
10.3.1 GERMANY 115
10.3.1.1 Advanced medical facilities and R&D investments to propel market 115
10.3.2 FRANCE 117
10.3.2.1 Rising elderly population to fuel market growth 117
10.3.3 UK 118
10.3.3.1 Innovation, technological advancements, and investments to drive market 118
10.3.4 SPAIN 120
10.3.4.1 Growing aging population and improvements in healthcare system to increase consumption 120
10.3.5 ITALY 121
10.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market 121
10.3.6 NETHERLANDS 123
10.3.6.1 Rising homecare treatment to increase demand 123
10.3.7 REST OF EUROPE 124
10.4 ASIA PACIFIC 126
10.4.1 CHINA 130
10.4.1.1 Investments in manufacturing medical devices to support market 130
10.4.2 JAPAN 131
10.4.2.1 Implementation of AI and big data technologies in healthcare industry to increase demand 131
10.4.3 INDIA 133
10.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand 133
10.4.4 SOUTH KOREA 135
10.4.4.1 Medical tourism to lead to market growth 135
10.4.5 REST OF ASIA PACIFIC 136
10.5 MIDDLE EAST & AFRICA 138
10.5.1 GCC COUNTRIES 141
10.5.1.1 Saudi Arabia 141
10.5.1.1.1 Government initiatives to support market growth 141
10.5.1.2 UAE 143
10.5.1.2.1 Government funding and rapidly developing private health sector to drive market 143
10.5.2 SOUTH AFRICA 144
10.5.2.1 Increasing awareness, testing, and treatment programs to drive market 144
10.5.3 EGYPT 146
10.5.3.1 Technological advancements and improving healthcare sector to fuel demand 146
10.5.4 REST OF MIDDLE EAST & AFRICA 147
10.6 SOUTH AMERICA 149
10.6.1 BRAZIL 151
10.6.1.1 Growing healthcare system to increase consumption 151
10.6.2 ARGENTINA 152
10.6.2.1 Rising prevalence of chronic diseases, aging population, and advances in medical sector to drive market 152
10.6.3 REST OF SOUTH AMERICA 154
11 COMPETITIVE LANDSCAPE 156
11.1 OVERVIEW 156
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025 156
11.3 REVENUE ANALYSIS, 2024 159
11.4 MARKET SHARE ANALYSIS, 2024 160
11.4.1 SAINT-GOBAIN 161
11.4.2 FREUDENBERG MEDICAL 161
11.4.3 THE LUBRIZOL CORPORATION 162
11.4.4 W. L. GORE & ASSOCIATES, INC. 162
11.4.5 TE CONNECTIVITY 162
11.5 COMPANY VALUATION AND FINANCIAL METRICS 162
11.6 BRAND COMPARISON 164
11.6.1 MEDICAL TUBING MARKET: BRAND COMPARISON 164
11.6.2 BIO-SIL TUBING 164
11.6.3 HELIXFLEX 165
11.6.4 ISOPLAST ETPU MEDICAL TUBING 165
11.6.5 GORE STA-PURE PUMP TUBING SERIES PFL 165
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 165
11.7.1 STARS 165
11.7.2 EMERGING LEADERS 165
11.7.3 PERVASIVE PLAYERS 166
11.7.4 PARTICIPANTS 166
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 167
11.7.5.1 Company footprint 167
11.7.5.2 Region footprint 168
11.7.5.3 Structure footprint 169
11.7.5.4 Material footprint 170
11.7.5.5 Application footprint 171
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 172
11.8.1 PROGRESSIVE COMPANIES 172
11.8.2 RESPONSIVE COMPANIES 172
11.8.3 DYNAMIC COMPANIES 172
11.8.4 STARTING BLOCKS 172
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 174
11.8.5.1 Detailed list of key startups/SMEs 174
11.8.5.2 Competitive benchmarking of startups/SMEs 175
11.9 COMPETITIVE SCENARIO 176
11.9.1 PRODUCT LAUNCHES 176
11.9.2 DEALS 178
11.9.3 OTHER DEVELOPMENTS 180
12 COMPANY PROFILES 182
12.1 KEY PLAYERS 182
12.1.1 SAINT-GOBAIN 182
12.1.1.1 Business overview 182
12.1.1.2 Products/Solutions/Services offered 183
12.1.1.3 Recent developments 186
12.1.1.3.1 Deals 186
12.1.1.4 MnM view 186
12.1.1.4.1 Right to win 186
12.1.1.4.2 Strategic choices 186
12.1.1.4.3 Weaknesses and competitive threats 186
12.1.2 FREUDENBERG MEDICAL 187
12.1.2.1 Business overview 187
12.1.2.2 Products/Solutions/Services offered 188
12.1.2.3 Recent developments 192
12.1.2.3.1 Product launches 192
12.1.2.3.2 Deals 192
12.1.2.3.3 Expansions 193
12.1.2.4 MnM view 194
12.1.2.4.1 Right to win 194
12.1.2.4.2 Strategic choices 194
12.1.2.4.3 Weaknesses and competitive threats 194
12.1.3 THE LUBRIZOL CORPORATION 195
12.1.3.1 Business overview 195
12.1.3.2 Products/Solutions/Services offered 196
12.1.3.3 Recent developments 198
12.1.3.3.1 Deals 198
12.1.3.3.2 Expansions 198
12.1.3.4 MnM view 199
12.1.3.4.1 Right to win 199
12.1.3.4.2 Strategic choices 199
12.1.3.4.3 Weaknesses and competitive threats 199
12.1.4 W. L. GORE & ASSOCIATES, INC. 200
12.1.4.1 Business overview 200
12.1.4.2 Products/Solutions/Services offered 200
12.1.4.3 MnM view 201
12.1.4.3.1 Right to win 201
12.1.4.3.2 Strategic choices 201
12.1.4.3.3 Weaknesses and competitive threats 201
12.1.5 NORDSON CORPORATION 202
12.1.5.1 Business overview 202
12.1.5.2 Products/Solutions/Services offered 203
12.1.5.3 Recent developments 205
12.1.5.3.1 Deals 205
12.1.5.4 MnM view 206
12.1.5.4.1 Right to win 206
12.1.5.4.2 Strategic choices 206
12.1.5.4.3 Weaknesses and competitive threats 206
12.1.6 TE CONNECTIVITY 207
12.1.6.1 Business overview 207
12.1.6.2 Products/Solutions/Services offered 208
12.1.6.3 Recent developments 209
12.1.6.3.1 Product launches 209
12.1.6.4 MnM view 209
12.1.7 ELKEM ASA 210
12.1.7.1 Business overview 210
12.1.7.2 Products/Solutions/Services offered 211
12.1.7.3 Recent developments 212
12.1.7.3.1 Deals 212
12.1.7.3.2 Expansions 212
12.1.7.4 MnM view 212
12.1.8 TRELLEBORG AB 213
12.1.8.1 Business overview 213
12.1.8.2 Products/Solutions/Services offered 214
12.1.8.3 Recent developments 216
12.1.8.3.1 Deals 216
12.1.8.3.2 Other developments 216
12.1.8.4 MnM view 216
12.1.9 RAUMEDIC AG 217
12.1.9.1 Business overview 217
12.1.9.2 Products/Solutions/Services offered 217
12.1.9.3 Recent developments 219
12.1.9.3.1 Product launches 219
12.1.9.3.2 Deals 219
12.1.9.3.3 Expansions 220
12.1.9.4 MnM view 220
12.1.10 TEKNOR APEX 221
12.1.10.1 Business overview 221
12.1.10.2 Products/Solutions/Services offered 221
12.1.10.3 Recent developments 222
12.1.10.3.1 Product launches 222
12.1.10.3.2 Deals 222
12.1.10.4 MnM view 223
12.1.11 SPECTRUM PLASTICS GROUP 224
12.1.11.1 Business overview 224
12.1.11.2 Products/Solutions/Services offered 224
12.1.11.3 Recent developments 226
12.1.11.3.1 Deals 226
12.1.11.3.2 Expansions 226
12.1.11.4 MnM view 227
12.1.12 ZEUS COMPANY LLC 228
12.1.12.1 Business overview 228
12.1.12.2 Products/Solutions/Services offered 228
12.1.12.3 Recent developments 230
12.1.12.3.1 Product launches 230
12.1.12.3.2 Expansions 230
12.1.12.4 MnM view 230
12.2 OTHER PLAYERS 231
12.2.1 ATAG SPA 231
12.2.2 DAVIS STANDARD 232
12.2.3 FBK MEDICAL TUBING 233
12.2.4 PROTERIAL CABLE AMERICA, INC. 234
12.2.5 ICO RALLY 235
12.2.6 ICU MEDICAL, INC. 236
12.2.7 KRATON CORPORATION 237
12.2.8 MICROLUMEN INC. 238
12.2.9 MDC INDUSTRIES 239
12.2.10 NEWAGE INDUSTRIES 240
12.2.11 OPTINOVA 241
12.2.12 PARKER HANNIFIN CORP. 242
12.2.13 TEEL PLASTICS 243
12.2.14 VESTA INC. 244
12.2.15 SMOOTH-BOR PLASTICS 245
13 APPENDIX 246
13.1 DISCUSSION GUIDE 246
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249
13.3 CUSTOMIZATION OPTIONS 251
13.4 RELATED REPORTS 251
13.5 AUTHOR DETAILS 252
LIST OF TABLES
TABLE 1 LIST OF KEY SECONDARY SOURCES 30
TABLE 2 SHARE OF POPULATION ABOVE 65 YEARS OF AGE, BY COUNTRY, 2020 43
TABLE 3 LIST OF STANDARDS AND REGULATIONS FOR MEDICAL TUBING 46
TABLE 4 CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION) 49
TABLE 5 HEALTHCARE SPENDING, 2023 (USD MILLION) 49
TABLE 6 MEDICAL TUBING MARKET: PORTER’S FIVE FORCES ANALYSIS 51
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%) 53
TABLE 8 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 54
TABLE 9 TRENDS OF PER CAPITA GDP, BY KEY COUNTRY, 2020–2023 (USD) 55
TABLE 10 GDP GROWTH ESTIMATE AND PROJECTION, BY KEY COUNTRY, 2024–2027 (USD) 55
TABLE 11 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, BY KEY COUNTRY, 2019–2022 56
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 15 IMPORT SCENARIO FOR HS CODE 3917-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 65
TABLE 16 EXPORT SCENARIO FOR HS CODE 3917-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 66
TABLE 17 ROLE OF COMPANIES IN MEDICAL TUBING ECOSYSTEM 67
TABLE 18 MEDICAL TUBING MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025 71
TABLE 19 TOP 10 PATENT OWNERS DURING LAST ELEVEN YEARS, 2015–2024 75
TABLE 20 MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 80
TABLE 21 MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 81
TABLE 22 MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 81
TABLE 23 MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 81
TABLE 24 MEDICAL TUBING MARKET, BY MATERIAL, 2021–2024 (KILOTON) 88
TABLE 25 MEDICAL TUBING MARKET, BY MATERIAL, 2025–2030 (KILOTON) 88
TABLE 26 MEDICAL TUBING MARKET, BY MATERIAL, 2021–2024 (USD MILLION) 89
TABLE 27 MEDICAL TUBING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 89
TABLE 28 MEDICAL TUBING MARKET, BY STRUCTURE, 2021–2024 (KILOTON) 96
TABLE 29 MEDICAL TUBING MARKET, BY STRUCTURE, 2025–2030 (KILOTON) 97
TABLE 30 MEDICAL TUBING MARKET, BY STRUCTURE, 2021–2024 (USD MILLION) 97
TABLE 31 MEDICAL TUBING MARKET, BY STRUCTURE, 2025–2030 (USD MILLION) 97
TABLE 32 MEDICAL TUBING MARKET, BY REGION, 2021–2024 (KILOTON) 102
TABLE 33 MEDICAL TUBING MARKET, BY REGION, 2025–2030 (KILOTON) 103
TABLE 34 MEDICAL TUBING MARKET, BY REGION, 2021–2024 (USD MILLION) 103
TABLE 35 MEDICAL TUBING MARKET, BY REGION, 2025–2030 (USD MILLION) 103
TABLE 36 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (KILOTON) 105
TABLE 37 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (KILOTON) 105
TABLE 38 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 105
TABLE 39 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 105
TABLE 40 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 106
TABLE 41 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 106
TABLE 42 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 106
TABLE 43 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 106
TABLE 44 US: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 107
TABLE 45 US: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 108
TABLE 46 US: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 108
TABLE 47 US: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 108
TABLE 48 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 109
TABLE 49 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 109
TABLE 50 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 110
TABLE 51 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 110
TABLE 52 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 111
TABLE 53 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 111
TABLE 54 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 111
TABLE 55 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 111
TABLE 56 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 113
TABLE 57 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 113
TABLE 58 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 113
TABLE 59 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 114
TABLE 60 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 114
TABLE 61 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 114
TABLE 62 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 115
TABLE 63 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 115
TABLE 64 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 116
TABLE 65 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 116
TABLE 66 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 116
TABLE 67 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 116
TABLE 68 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 117
TABLE 69 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 117
TABLE 70 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 118
TABLE 71 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 118
TABLE 72 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 119
TABLE 73 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 119
TABLE 74 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 119
TABLE 75 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 119
TABLE 76 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 120
TABLE 77 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 120
TABLE 78 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 121
TABLE 79 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 121
TABLE 80 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 122
TABLE 81 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 122
TABLE 82 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 122
TABLE 83 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 123
TABLE 84 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 123
TABLE 85 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 124
TABLE 86 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 124
TABLE 87 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 124
TABLE 88 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 125
TABLE 89 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 125
TABLE 90 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 125
TABLE 91 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 125
TABLE 92 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 127
TABLE 93 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 128
TABLE 94 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 128
TABLE 95 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 128
TABLE 96 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 128
TABLE 97 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 129
TABLE 98 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 129
TABLE 99 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 129
TABLE 100 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 130
TABLE 101 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 131
TABLE 102 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 131
TABLE 103 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 131
TABLE 104 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 132
TABLE 105 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 132
TABLE 106 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 132
TABLE 107 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 133
TABLE 108 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 134
TABLE 109 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 134
TABLE 110 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 134
TABLE 111 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134
TABLE 112 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 135
TABLE 113 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 135
TABLE 114 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 136
TABLE 115 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 136
TABLE 116 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 137
TABLE 117 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 137
TABLE 118 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 137
TABLE 119 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 138
TABLE 120 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (KILOTON) 138
TABLE 121 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (KILOTON) 139
TABLE 122 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 139
TABLE 123 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 139
TABLE 124 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 140
TABLE 125 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 140
TABLE 126 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 140
TABLE 127 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 141
TABLE 128 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 142
TABLE 129 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 142
TABLE 130 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 142
TABLE 131 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 143
TABLE 132 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 143
TABLE 133 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 144
TABLE 134 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 144
TABLE 135 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144
TABLE 136 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 145
TABLE 137 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 145
TABLE 138 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 145
TABLE 139 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 146
TABLE 140 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 146
TABLE 141 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 146
TABLE 142 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 147
TABLE 143 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147
TABLE 144 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 147
TABLE 145 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 148
TABLE 146 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 148
TABLE 147 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 148
TABLE 148 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (KILOTON) 149
TABLE 149 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (KILOTON) 149
TABLE 150 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 149
TABLE 151 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 150
TABLE 152 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 150
TABLE 153 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 150
TABLE 154 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 150
TABLE 155 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 151
TABLE 156 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 151
TABLE 157 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 151
TABLE 158 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 152
TABLE 159 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 152
TABLE 160 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 153
TABLE 161 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 153
TABLE 162 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 153
TABLE 163 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 153
TABLE 164 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (KILOTON) 154
TABLE 165 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (KILOTON) 154
TABLE 166 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 154
TABLE 167 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 155
TABLE 168 MEDICAL TUBING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020–2025 157
TABLE 169 MEDICAL TUBING MARKET: DEGREE OF COMPETITION, 2024 161
TABLE 170 MEDICAL TUBING MARKET: REGION FOOTPRINT 168
TABLE 171 MEDICAL TUBING MARKET: STRUCTURE FOOTPRINT 169
TABLE 172 MEDICAL TUBING MARKET: MATERIAL FOOTPRINT 170
TABLE 173 MEDICAL TUBING MARKET: APPLICATION FOOTPRINT 171
TABLE 174 MEDICAL TUBING MARKET: KEY STARTUPS/SMES 174
TABLE 175 MEDICAL TUBING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 175
TABLE 176 MEDICAL TUBING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 176
TABLE 177 MEDICAL TUBING MARKET: DEALS, JANUARY 2020–MARCH 2025 178
TABLE 178 MEDICAL TUBING MARKET: OTHER DEVELOPMENTS,
JANUARY 2020–MARCH 2025 180
TABLE 179 SAINT-GOBAIN: COMPANY OVERVIEW 182
TABLE 180 SAINT-GOBAIN: PRODUCTS/SOLUTIONS/SERVICES OFFERED 183
TABLE 181 SAINT-GOBAIN: DEALS, JANUARY 2020–MARCH 2025 186
TABLE 182 FREUDENBERG MEDICAL: COMPANY OVERVIEW 187
TABLE 183 FREUDENBERG MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 188
TABLE 184 FREUDENBERG MEDICAL: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 192
TABLE 185 FREUDENBERG MEDICAL: DEALS, JANUARY 2020–MARCH 2025 192
TABLE 186 FREUDENBERG MEDICAL: EXPANSIONS, JANUARY 2020–MARCH 2025 193
TABLE 187 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW 195
TABLE 188 THE LUBRIZOL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 196
TABLE 189 THE LUBRIZOL CORPORATION: DEALS, JANUARY 2020–MARCH 2025 198
TABLE 190 THE LUBRIZOL CORPORATION: EXPANSIONS, JANUARY 2020–MARCH 2025 198
TABLE 191 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 200
TABLE 192 W. L. GORE & ASSOCIATES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200
TABLE 193 NORDSON CORPORATION: COMPANY OVERVIEW 202
TABLE 194 NORDSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 203
TABLE 195 NORDSON CORPORATION: DEALS, JANUARY 2020–MARCH 2025 205
TABLE 196 TE CONNECTIVITY: COMPANY OVERVIEW 207
TABLE 197 TE CONNECTIVITY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 208
TABLE 198 TE CONNECTIVITY: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 209
TABLE 199 ELKEM ASA: COMPANY OVERVIEW 210
TABLE 200 ELKEM ASA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 211
TABLE 201 ELKEM ASA: DEALS, JANUARY 2020–MARCH 2025 212
TABLE 202 ELKEM ASA: EXPANSIONS, JANUARY 2020–MARCH 2025 212
TABLE 203 TRELLEBORG AB: COMPANY OVERVIEW 213
TABLE 204 TRELLEBORG AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214
TABLE 205 TRELLEBORG AB: DEALS, JANUARY 2020–MARCH 2025 216
TABLE 206 TRELLEBORG AB: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2025 216
TABLE 207 RAUMEDIC AG: COMPANY OVERVIEW 217
TABLE 208 RAUMEDIC AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 217
TABLE 209 RAUMEDIC AG: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 219
TABLE 210 RAUMEDIC AG: DEALS, JANUARY 2020–MARCH 2025 219
TABLE 211 RAUMEDIC AG: EXPANSIONS, JANUARY 2020–MARCH 2025 220
TABLE 212 TEKNOR APEX: COMPANY OVERVIEW 221
TABLE 213 TEKNOR APEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED 221
TABLE 214 TEKNOR APEX: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 222
TABLE 215 TEKNOR APEX: DEALS, JANUARY 2020–MARCH 2025 222
TABLE 216 SPECTRUM PLASTICS GROUP: COMPANY OVERVIEW 224
TABLE 217 SPECTRUM PLASTICS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224
TABLE 218 SPECTRUM PLASTICS GROUP: DEALS, JANUARY 2020–MARCH 2025 226
TABLE 219 SPECTRUM PLASTICS GROUP: EXPANSIONS, JANUARY 2020–MARCH 2025 226
TABLE 220 ZEUS COMPANY LLC: COMPANY OVERVIEW 228
TABLE 221 ZEUS COMPANY LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 228
TABLE 222 ZEUS COMPANY LLC: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 230
TABLE 223 ZEUS COMPANY LLC: EXPANSIONS, JANUARY 2020–MARCH 2025 230
TABLE 224 ATAG SPA: COMPANY OVERVIEW 231
TABLE 225 DAVIS STANDARD: COMPANY OVERVIEW 232
TABLE 226 FBK MEDICAL TUBING: COMPANY OVERVIEW 233
TABLE 227 PROTERIAL CABLE AMERICA, INC.: COMPANY OVERVIEW 234
TABLE 228 ICO RALLY: COMPANY OVERVIEW 235
TABLE 229 ICU MEDICAL, INC.: COMPANY OVERVIEW 236
TABLE 230 KRATON CORPORATION: COMPANY OVERVIEW 237
TABLE 231 MICROLUMEN INC.: COMPANY OVERVIEW 238
TABLE 232 MDC INDUSTRIES: COMPANY OVERVIEW 239
TABLE 233 NEWAGE INDUSTRIES: COMPANY OVERVIEW 240
TABLE 234 OPTINOVA: COMPANY OVERVIEW 241
TABLE 235 PARKER HANNIFIN CORP.: COMPANY OVERVIEW 242
TABLE 236 TEEL PLASTICS: COMPANY OVERVIEW 243
TABLE 237 VESTA INC.: COMPANY OVERVIEW 244
TABLE 238 SMOOTH-BOR PLASTICS: COMPANY OVERVIEW 245
LIST OF FIGURES
FIGURE 1 MEDICAL TUBING MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 MEDICAL TUBING MARKET: RESEARCH DESIGN 29
FIGURE 3 MEDICAL TUBING MARKET: BOTTOM-UP APPROACH 33
FIGURE 4 MEDICAL TUBING MARKET: TOP-DOWN APPROACH 33
FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL TUBING MARKET, TOP-DOWN APPROACH 34
FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS 34
FIGURE 7 MEDICAL TUBING MARKET: DATA TRIANGULATION 35
FIGURE 8 RUBBERS TO BE FASTEST-GROWING MATERIAL SEGMENT IN MEDICAL TUBING MARKET DURING FORECAST PERIOD 38
FIGURE 9 CATHETERS & CANNULAS APPLICATION TO LEAD OVERALL MARKET DURING FORECAST PERIOD 38
FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 39
FIGURE 11 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MEDICAL TUBING MARKET DURING FORECAST PERIOD 40
FIGURE 12 SPECIALTY POLYMERS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40
FIGURE 13 BULK DISPOSABLE TUBING SEGMENT TO LEAD OVERALL MARKET BY 2030 41
FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 41
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL TUBING MARKET 42
FIGURE 16 MEDICAL TUBING MARKET: PORTER’S FIVE FORCES ANALYSIS 51
FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 53
FIGURE 18 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 54
FIGURE 19 MEDICAL TUBING MARKET: VALUE CHAIN ANALYSIS 58
FIGURE 20 IMPORT DATA FOR HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020–2024 (USD MILLION) 64
FIGURE 21 EXPORT DATA RELATED TO HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020–2024 (USD MILLION) 65
FIGURE 22 MEDICAL TUBING MARKET: ECOSYSTEM ANALYSIS 66
FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN MEDICAL TUBING MARKET 68
FIGURE 24 MEDICAL TUBING MARKET: GRANTED PATENTS, 2015–2024 73
FIGURE 25 NUMBER OF PATENTS PER YEAR, 2015–2024 73
FIGURE 26 LEGAL STATUS OF PATENTS, 2015–2024 74
FIGURE 27 TOP JURISDICTION, BY DOCUMENT, 2015–2024 74
FIGURE 28 TOP 10 PATENT APPLICANTS, 2015–2024 75
FIGURE 29 AVERAGE SELLING PRICE, BY REGION, 2021–2024 (USD/KG) 76
FIGURE 30 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER,
2024 (USD/KG) 77
FIGURE 31 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021–2024 (USD/KG) 77
FIGURE 32 MEDICAL TUBING, INVESTMENT AND FUNDING SCENARIO, 2020–2024 78
FIGURE 33 CATHETERS & CANNULAS TO BE LARGEST APPLICATION OF MEDICAL TUBING MARKET DURING FORECAST PERIOD 80
FIGURE 34 RUBBERS SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD 88
FIGURE 35 MULTI-LUMEN SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD 96
FIGURE 36 INDIA TO BE FASTEST-GROWING MARKET FOR MEDICAL TUBING DURING FORECAST PERIOD 102
FIGURE 37 NORTH AMERICA: MEDICAL TUBING MARKET SNAPSHOT 104
FIGURE 38 EUROPE: MEDICAL TUBING MARKET SNAPSHOT 112
FIGURE 39 ASIA PACIFIC: MEDICAL TUBING MARKET SNAPSHOT 127
FIGURE 40 MEDICAL TUBING MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2021–2023 159
FIGURE 41 MEDICAL TUBING MARKET SHARE ANALYSIS, 2024 160
FIGURE 42 MEDICAL TUBING MARKET: COMPANY VALUATION OF LEADING COMPANIES, 2024 163
FIGURE 43 MEDICAL TUBING MARKET: FINANCIAL METRICS OF LEADING COMPANIES, 2024 163
FIGURE 44 BRAND COMPARISON 164
FIGURE 45 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2024 166
FIGURE 46 MEDICAL TUBING MARKET: COMPANY FOOTPRINT 167
FIGURE 47 MEDICAL TUBING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 173
FIGURE 48 SAINT-GOBAIN: COMPANY SNAPSHOT 183
FIGURE 49 FREUDENBERG GROUP: COMPANY SNAPSHOT 188
FIGURE 50 NORDSON CORPORATION: COMPANY SNAPSHOT 203
FIGURE 51 TE CONNECTIVITY: COMPANY SNAPSHOT 208
FIGURE 52 ELKEM ASA: COMPANY SNAPSHOT 211
FIGURE 53 TRELLEBORG AB: COMPANY SNAPSHOT 214
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11